Form 4 for GILD Gilead Sciences
Accepted 2024-06-11 00:00:00 ET · period of report 2024-06-10 · accession 0001127602-24-018413 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-11 | 2024-06-10 | GILD | Parsey Merdad | Chief Medical Off | M - OptEx | — | +3,820 | 100.1K | +4% | — |
| D | 2024-06-11 | 2024-06-10 | GILD | Parsey Merdad | Chief Medical Off | F - Tax | $65.25 | -1,744 | 98.4K | -2% | -$113.8K |
| D | 2024-06-11 | 2024-06-10 | GILD | Parsey Merdad | Chief Medical Off | M - OptEx | — | -3,820 | 44.4K | -8% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-10 | M | A | 3,820 | — | 100,124 | D | — | — | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| 2 | Common | Common Stock | 2024-06-10 | F | D | 1,744 | $65.25 | 98,380 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2024-06-10 | M | D | 3,820 | — | 44,394 | D | — · — to — | 3,820 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested. |